Mechanistically, miR-300b-3p targets histone deacetylase 4 (HDAC4) as the overexpression of HDAC4 reduced the increased apoptosis induced by inhibiting miR-200b-3p, suggesting that miR-200b-3p is a potential therapeutic target for atherosclerosis. This evidence concerns the gene HDAC4 and atherosclerosis.